Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans

1. A method of treating a person with diabetes comprising:

administering a therapeutically effective amount of a pomegranate juice composition to a diabetic patient, wherein said pomegranate juice composition comprises sugars from pomegranate,

wherein diabetic parameters of said diabetic patient are not significantly affected by said therapeutically effective amount of said pomegranate juice composition, and wherein said pomegranate juice composition is prepared by:

crushing and squeezing whole fruits of pomegranate including inner and outer peels and seeds to yield a soluble juice component and an insoluble by-product component; separating the soluble juice component from the insoluble by-product component; and removing the insoluble by-product component therefrom to produce said pomegranate juice composition.

2. The method of claim 1 , wherein said pomegranate juice composition is administered to reduce oxidative stress in said diabetic patient.

3. The method of claim 1 , wherein said pomegranate juice composition is administered to alleviate or prevent an atherosclerotic condition in said diabetic patient.

4. The method of claim 1 , wherein said pomegranate juice composition is administered to reduce macrophage cholesterol accumulation and foam cell formation in said diabetic patient.

5. The method of claim 1 , wherein said pomegranate juice composition comprises concentrated pomegranate juice.

6. The method of claim 1 , wherein said pomegranate juice composition further comprises an additional pomegranate extract comprising at least one of a seed component, an inner peel component, and an outer peel component of a pomegranate fruit.

7. The method of claim 1 , wherein said composition comprises an increased polyphenol count above levels naturally occurring in pomegranate juice.

8. The method of claim 1 , wherein said composition comprises a pomegranate polyphenol fraction.

9. A method of treating a person with diabetes comprising:

administering a therapeutically effective amount of a pomegranate juice composition to a diabetic patient, wherein said pomegranate juice composition comprises sugars from pomegranate,

wherein diabetic parameters of said diabetic patient are not significantly affected by said therapeutically effective amount of said pomegranate juice composition, and

wherein said pomegranate juice composition is prepared by:

crushing and squeezing whole fruits of pomegranate including inner and outer peels and seeds to yield a soluble juice component and an insoluble by-product component;

separating the soluble juice component from the insoluble by-product component;

resuspending the insoluble by-product component in an aqueous medium;

crushing, squeezing, and mixing the resuspended by-product component to yield a soluble portion of the insoluble portion;

separating the soluble portion from the insoluble portion; and

combining the soluble portion with the soluble juice component to produce said pomegranate juice composition.

10. A method of treating a person with diabetes related atherosclerotic complications comprising:

determining a presence of atherosclerotic complications in a diabetic patient; and

administering a composition comprising a therapeutically effective amount of a pomegranate extract to said diabetic patient to treat said atherosclerotic complication without an adverse effect on diabetic parameters,

wherein said pomegranate extract is prepared by a process comprising:

crushing and squeezing whole fruits of pomegranate including inner and outer peels and seeds to yield a soluble juice component and an insoluble by-product component; and

separating the soluble juice component from the insoluble by-product component and removing the insoluble by-product component therefrom to produce said pomegranate extract.

11. The method of claim 10 , wherein said diabetic parameters comprise blood glucose, hemoglobin (Hb) A1c, insulin and C-peptide levels.

12. The method of claim 11 , wherein said pomegranate extract is a solid.

13. The method of claim 11 , wherein said pomegranate extract comprises a pomegranate polyphenol fraction.

14. The method of claim 11 , wherein said pomegranate extract comprises an increased polyphenol count above levels naturally occurring in pomegranate juice.

15. The method of claim 11 , wherein said pomegranate extract comprises pomegranate seed oil.

16. The method of claim 11 , wherein the administration of said pomegranate extract reduces macrophage cholesterol accumulation and foam cell formation in said person with diabetes.